1.
Mobile phone technologies improve adherence to antiretroviral treatment in a resource-limited setting: a randomized controlled trial of text message reminders
by POP-ELECHES, Cristian
AIDS (London), 2011, Vol.25 (6), p.825-834
2.
TB-IRIS, T-cell activation, and remodeling of the T-cell compartment in highly immunosuppressed HIV-infected patients with TB
by Haridas, Viraga
AIDS (London), 2015, Vol.29 (3), p.263-273
3.
Social capital and HIV Competent Communities: The role of community groups in managing HIV/AIDS in rural Zimbabwe
by Campbell, Catherine
AIDS care, 2013, Vol.25 (sup1), p.S114-S122
4.
Gender differences in antiretroviral treatment outcomes of HIV patients in rural Uganda
by Kipp, Walter
AIDS care, 2010, Vol.22 (3), p.271-278
5.
Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model
by Granich, Reuben M, MD
The Lancet (British edition), 2009, Vol.373 (9657), p.48-57
6.
Intolerance of dolutegravir-containing combination antiretroviral therapy regimens in real-life clinical practice
by de Boer, Mark G.J
AIDS (London), 2016, Vol.30 (18), p.2831-2834
7.
Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis
by Rajasingham, Radha, Dr
The Lancet infectious diseases, 2017, Vol.17 (8), p.873-881
8.
Coformulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide, for initial treatment of HIV-1 infection (GS-US...
by Sax, Paul E
The Lancet (British edition), 2017, Vol.390 (10107), p.2073-2082
9.
Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection (GS-US-380-1489): a double-blind, multi...
by Gallant, Joel
The Lancet (British edition), 2017, Vol.390 (10107), p.2063-2072
10.
Antiretroviral Adherence Among Rural Compared to Urban Veterans with HIV Infection in the United States
by Ohl, Michael E
AIDS and behavior, 2012, Vol.17 (1), p.174-180
11.
HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage
by Mathers, Bradley M, Dr
The Lancet (British edition), 2010, Vol.375 (9719), p.1014-1028
12.
Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis
by Müller, Monika, BA
The Lancet infectious diseases, 2010, Vol.10 (4), p.251-261
13.
Interventions to improve adherence to antiretroviral therapy: a rapid systematic review
by Chaiyachati, Krisda H
AIDS (London), 2014, Vol.28 Suppl 2, p.S187-S204
14.
Early antiretroviral therapy limits SIV reservoir establishment to delay or prevent post-treatment viral rebound
by Okoye, Afam A
Nature medicine, 2018, Vol.24 (9), p.1430-1440
15.
Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy
by MAY, Margaret T
AIDS (London), 2014, Vol.28 (8), p.1193-1202
16.
Operational assessment of access to ART in rural Africa: the example of Kisantu in Democratic Republic of the Congo
by Van Rompaey, Sara
AIDS care, 2011, Vol.23 (6), p.686-693
17.
Depression Treatment Enhances Adherence to Antiretroviral Therapy: a Meta-Analysis
by Sin, Nancy L
Annals of behavioral medicine, 2013, Vol.47 (3), p.259-269
18.
Antiretroviral therapy and management of HIV infection
by Volberding, Paul A, Prof
The Lancet (British edition), 2010, Vol.376 (9734), p.49-62
19.
Efficacy and safety of once daily elvitegravir versus twice daily raltegravir in treatment-experienced patients with HIV-1 receiving a ritonavir-boosted protease inhibitor: randomi...
by Molina, Jean-Michel, Dr
The Lancet infectious diseases, 2012, Vol.12 (1), p.27-35
20.
Could antiretroviral neurotoxicity play a role in the pathogenesis of cognitive impairment in treated HIV disease?
by Underwood, Jonathan
AIDS (London), 2015, Vol.29 (3), p.253-261
